Additional myeloablation with 52Fe before bone marrow transplantation

Bone Marrow Transplantation

Volumn 19, Issue 3, 1997, Pages 191-196

  Jacquy, C ^a   Ferrant, A ^a,b   Leners, N ^a   Cogneau, M ^a   Jamar, F ^a   Michaux, J L ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

52Fe; Bone marrow transplantation; Radiotherapy

Indexed keywords

IRON 52; RADIOISOTOPE; IRON;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG SAFETY; FEMALE; FOLLOW UP; HEMATOPOIESIS; HEMOGLOBINOPATHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL TIME; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEOPLASM;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IRON RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASMS;

EID: 0030614403     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700638     Document Type: Article

References (18)

1. Finch CA, Deubelbeiss K, Cook JD et al. Ferrokinetics in man. Medicine 1970; 49: 17-53.
2. François PE, Szur L. Use of iron-52 as a radioactive tracer. Nature 1958; 182: 1665-1667.
3. 52Fe. Br J Haematol 1980; 45: 447-457.
4. Robertson JS, Price RR, Budinger TF et al. Radiation absorbed doses from iron-52, iron-55, and iron-59 used to study ferrokinetics. J Nucl Med 1983; 24: 339-348.
5. 52Fe for additional marrow ablation before bone marrow transplantation. Blood 1993; 81: 3435-3439.
6. Bothwell TH, Charlton RW, Cook JD, Finch CA (eds.). In: Iron Metabolism in Man. Blackwell Scientific: Oxford, 1979, pp 327-349.
7. Loevinger R, Berman M. A revised schema for calculating the absorved dose from biologically distributed radionuclides. In: MIRD Pamphlet no. 1, revised, Society of Nuclear Medicine: New York, NY, March 1976.
8. Snyder WS, Ford MR, Warner GG et al. "S" absorbed dose per unit cumulated activity for selected radionuclides and organs. In MIRD Pamphlet no. 11, revised, Society of Nuclear Medicine: New York, NY, October 1975.
9. Clift RA, Buckner CD, Appelbaum FR et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood 1990; 76: 1867-1871.
10. Clift RA, Buckner CD, Appelbaum FR et al. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase. A randomized trial or two irradiation regimens. Blood 1991; 77: 1660-1665.
11. Appelbaum FR, Brown P, Sandmaier B et al. Antibody-radionuclide conjugates as part of a myeloablative preparative regimen for marrow transplantation. Blood 1989; 73: 2202-2208.
12. 131I-labeled anti-CD45 antibody combined with cyclophosphamide and total body irradiation. Blood 1995; 85: 1122-1131.
13. Press OW, Eary JF, Appelbaum FR et al. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. New Engl J Med 1993; 329: 1219-1224.
14. Keeling AA, Vaughan ATM, Beaney RP et al. Yttrium-90-EDTMP: a radiotherapeutic agent in the treatment of leukaemias. Br J Cancer 1989; 60: 74-78.
15. 166Ho-EDTMP. Blood 1992; 80: 1608-1613.
16. Reed GB, Cox AJ. The human liver after radiation injury. A form of veno-occlusive disease. Am J Pathol 1966; 48: 597-611.
17. Kraut JW, Kaplan HS, Bagshaw MA. Combined fractionated isotopic and external irradiation of the liver in Hodgkin's disease. A study of 21 patients. Cancer 1972; 30: 39-46.
18. Bodenberger U, Kolb HJ, Rieder I et al. Fractionated total body irradiation and autologous bone marrow transplantation in dogs: hemopoietic recovery after various marrow cell doses. Exp Hematol 1980; 8: 384-394.